IL-4-mediated fine tuning of IL-12p70 production by human DC

European Journal of Immunology

Volumn 38, Issue 11, 2008, Pages 3138-3149

  Guenova, Emmanuella ^a   Volz, Thomas ^a   Sauer, Karin ^a   Kaesler, Susanne ^a   Müller, Martin R ^b   Wölbing, Florian ^a   Chen, KoMing ^a   Schwärzler, Christoph ^c   Brossart, Peter ^d   Röcken, Martin ^a   Biedermann, Tilo ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Novartis Institutes for BioMedical Research Vienna   (Austria)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Cytokines; DC; Human inflammation; Skin

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 4; GAMMA INTERFERON; INTERLEUKIN 12;

ANTIBODY BLOOD LEVEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; BIOSYNTHESIS; DOSE RESPONSE; IMMUNOLOGY; IMMUNOPHENOTYPING; TIME;

DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; TH1 CELLS; TIME FACTORS;

EID: 58149328613     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838463     Document Type: Article

References (72)

1. Shortman, K. and Naik, S. H., Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007. 7: 19-30.
2. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
3. Blander, J. M. and Medzhitov, R., Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006. 440: 808-812.
4. Dudziak, D., Kamphors, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C. et al., Differential antigen processing by dendritic cell subsets in vivo. Science 2007. 315: 107-111.
5. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994. 179: 1109-1118.
6. Bender, A., Sapp, M., Schuler, G., Steinman, R. M. and Bhardwaj, N., Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 1996. 196: 121-135.
7. Randolph, G. J., Inaba, K., Robbiani, D. F., Steinman, R. M. and Müller, W. A., Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999. 11: 753-761.
8. Geissmann, F., Jung, S. and Littman, D. R., Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003. 19: 71-82.
9. Ginhoux, F., Tacke, F., Angeli, V., Bogunovic, M., Loubeau, M., Dai, X. M., Stanley, E. R. et al., Langerhans cells arise from monocytes in vivo. Nat. Immunol. 2006. 7: 265-273.
10. Leon, B., Lopez-Bravo, M. and Ardavin, C., Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007. 26: 519-531.
11. Röcken, M., Urban, J. and Shevach, E. M., Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo. J. Exp. Med. 1994. 179: 1885-1893.
12. Le Gros, G., Ben-Sasson, S. Z., Seder, R., Finkelman, F. D. and Paul, W. E., Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 1990. 172: 921-929.
13. Hochrein, H., O'Keeffe, M., Luft, T., Vandenabeele, S., Grumont, R. J., Maraskovsky, E. and Shortman, K., Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 2000. 192: 823-833.
14. Yao, Y., Li, W., Kaplan, M. H. and Chang, C. H., Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J. Exp. Med. 2005. 201: 1899-1903.
15. Biedermann, T., Zimmermann, S., Himmelrich, H., Gumy, A., Egeter, O., Sakrauski, A. K., Seegmüller, I. et al., IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat. Immunol. 2001. 2: 1054-1060.
16. Sadick, M. D., Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S. and Locksley, R. M., Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 1990. 171: 115-127.
17. Kalinski, P., Smits, H. H., Schuitemaker, J. H., Vieira, P. L., van Eijk, M., de Jong, E. C.,Wierenga, E. A. and Kapsenberg, M. L., IL-4 is a mediator of IL-12p70 induction by human Th2 cells: Reversal of polarized Th2 phenotype by dendritic cells. J. Immunol. 2000. 165: 1877-1881.
18. Hamid, Q., Boguniewicz, M. and Leung, D. Y., Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J. Clin. Invest. 1994. 94: 870-876.
19. Bieber, T., Atopic dermatitis. N. Engl. J. Med. 2008. 358: 1483-1494.
20. Novak, N. and Bieber, T., The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis. J. Am. Acad. Dermatol. 2005. 53: S171-S176.
21. Homey, B., Steinhoff, M., Ruzicka, T. and Leung, D. Y., Cytokines and chemokines orchestrate atopic skin inflammation. J. Allergy Clin. Immunol. 2006. 118: 178-189.
22. Langenkamp, A., Messi, M., Lanzavecchia, A. and Sallusto, F., Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 2000. 1: 311-316.
23. Seager Danciger, J., Lutz, M., Hama, S., Cruz, D., Castrillo, A., Lazaro, J., Phillips, R. et al., Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation. J. Immunol. Methods 2004. 288: 123-134.
24. Aste-Amezaga, M., Ma, X., Sartori, A. and Trinchieri, G., Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 1998. 160: 5936-5944.
25. D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M. and Trinchieri, G., Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 1993. 178: 1041-1048.
26. Trinchieri, G., Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003. 3: 133-146.
27. del Hoyo, G. M., Martin, P., Vargas, H. H., Ruiz, S., Arias, C. F. and Ardavin, C., Characterization of a common precursor population for dendritic cells. Nature 2002. 415: 1043-1047.
28. Liu, K., Waskow, C., Liu, X., Yao, K., Hoh, J. and Nussenzweig, M., Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 2007. 8: 578-583.
29. Ebner, S., Ratzinger, G., Krosbacher, B., Schmuth, M.,Weiss, A., Reider, D., Kroczek, R. A. et al., Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4. J. Immunol. 2001. 166: 633-641.
30. Geissmann, F., The origin of dendritic cells. Nat. Immunol. 2007. 8: 558-560.
31. Katz, S. I., Tamaki, K. and Sachs, D. H., Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 1979. 282: 324-326.
32. Wu, L. and Liu, Y. J., Development of dendritic-cell lineages. Immunity 2007. 26: 741-750.
33. Tacke, F. and Randolph, G. J., Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006. 211: 609-618.
34. Cravens, P. D., Hayashida, K., Davis, L. S., Nanki, T. and Lipsky, P. E., Human peripheral blood dendritic cells and monocyte subsets display similar chemokine receptor expression profiles with differential migratory responses. Scand. J. Immunol. 2007. 65: 514-524.
35. Chan, L. S., Robinson, N. and Xu, L., Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: An experimental animal model to study atopic dermatitis. J. Invest. Dermatol. 2001. 117: 977-983.
36. Grewe, M., Bruijnzeel-Koomen, C. A., Schopf, E., Thepen, T., Langeveld- Wildschut, A. G., Ruzicka, T. and Krutmann, J., A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today 1998. 19: 359-361.
37. Elbe-Bürger, A., Egyed, A., Olt, S., Klubal, R., Mann, U., Rappersberger, K., Rot, A. and Stingl, G., Overexpression of IL-4 alters the homeostasis in the skin. J. Invest. Dermatol. 2002. 118: 767-778.
38. Novak, N., Bieber, T. and Leung, D. Y., Immune mechanisms leading to atopic dermatitis. J. Allergy Clin. Immunol. 2003. 112: S128-S139.
39. Itano, A. A. and Jenkins, M. K., Antigen presentation to naive CD4 T cells in the lymph node. Nat. Immunol. 2003. 4: 733-739.
40. Murphy, K. M., Ouyang, W., Farrar, J. D., Yang, J., Ranganath, S., Asnagli, H., Afkarian, M. and Murphy, T. L., Signaling and transcription in T helper development. Annu. Rev. Immunol. 2000. 18: 451-494.
41. Rossi, M. and Young, J. W., Human dendritic cells: Potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J. Immunol. 2005. 175: 1373-1381.
42. Geijtenbeek, T. B., van Vliet, S. J., Engering, A., t Hart, B. A. and van Kooyk, Y., Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 2004. 22: 33-54.
43. Munz, C., Steinman, R. M. and Fujii, S., Dendritic cell maturation by innate lymphocytes: Coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 2005. 202: 203-207.
44. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767-811.
45. Leung, D. Y. and Bieber, T., Atopic dermatitis. Lancet 2003. 361: 151-160.
46. Grewe, M., Gyufko, K., Schöpf, E. and Krutmann, J., Lesional expression of interferon-gamma in atopic eczema. Lancet 1994. 343: 25-26.
47. Biedermann, T., Schwäzler, C., Lametschwandtner, G., Thoma, G., Carballido-Perrig, N., Kund, J., de Vries, J. E. et al., Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo. Eur. J. Immunol. 2002. 32: 3171-3180.
48. Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M. and Röcken, M., Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 1994. 180: 1961-1966.
49. Ghoreschi, K., Thomas, P., Breit, S., Dugas, M., Mailhammer, R., van Eden, W., van der Zee, R. et al., Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat. Med. 2003. 9: 40-46.
50. Biedermann, T., Mailhammer, R., Mai, A., Sander, C., Ogilvie, A., Brombacher, F., Maier, K. et al., Reversal of established delayed type hypersensitivity reactions following therapy with IL-4 or antigen-specific Th2 cells. Eur. J. Immunol. 2001. 31: 1582-1591.
51. Biedermann, T., Dissecting the role of infections in atopic dermatitis. Acta Derm. Venereol. 2006. 86: 99-109.
52. Biedermann, T. and R ̈ocken, M., Th1/Th2 balance in atopy. Springer Semin. Immunopathol. 1999. 21: 295-316.
53. Spergel, J. M., Mizoguchi, E., Oettgen, H., Bhan, A. K., and Geha, R. S., Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest. 1999. 103: 1103-1111.
54. Dearman, R. J. and Kimber, I., Role of CD4(+) T helper 2-type cells in cutaneous inflammatory responses induced by fluorescein isothiocyanate. Immunology 2000. 101: 442-451.
55. Takakura, M., Takeshita, F., Aihara, M., Xin, K. Q., Ichino, M., Okuda, K. and Ikezawa, Z., Hyperproduction of IFN-gamma by CpG oligodeoxynucleotide-induced exacerbation of atopic dermatitis-like skin lesion in some NC/Nga mice. J. Invest. Dermatol. 2005. 125: 1156-1162.
56. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R. et al., Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 1989. 170: 827-845.
57. Kumar, R. K., Herbert, C., Webb, D. C., Li, L. and Foster, P. S., Effects of anticytokine therapy in a mouse model of chronic asthma. Am. J. Respir. Crit. Care Med. 2004. 170: 1043-1048.
58. Truyen, E., Coteur, L., Dilissen, E., Overbergh, L., Dupont, L. J., Ceuppens, J. L. and Bullens, D. M. A., Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax 2006. 61: 202-208.
59. Kumar, R. K.,Webb, D. C., Herbert, C. and Foster, P. S., Interferon-gamma as a possible target in chronic asthma. Inflamm. Allergy Drug Targets 2006. 5: 253-256.
60. Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M. P., Maggi, E., Trinchieri, G. and Romagnani, S., Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 1993. 177: 1199-1204.
61. Hsieh, C. S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A. and Murphy, K. M., Development of TH1 CD41+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993. 260: 547-549.
62. Ardavin, C., Amigorena, S. and Reis e Sousa, C., Dendritic cells: immunobiology and cancer immunotherapy. Immunity 2004. 20: 17-23.
63. Shedlock, D. J. and Shen H., Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003. 300: 337-339.
64. Sun, J. C. and Bevan, M. J., Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003. 300: 339-342.
65. Janssen, E. M., Lemmens, E. E.,Wolfe, T., Christen, U., von Herrath, M. G. and Schoenberger, S. P., CD41+ T cells are required for secondary expansion and memory in CD81+ T lymphocytes. Nature 2003. 421: 852-856.
66. Hung, K., Hayashi, R., Lafond-Walker, A., Löwenstein, C., Pardoll, D. and Levitsky, H., The central role of CD4(+) T cells in the antitumor immune response. J. Exp. Med. 1998. 188: 2357-2368.
67. Pippin, B. A., Rosenstein, M., Jacob, W. F., Chiang, Y. and Lotze, M. T., Local IL-4 delivery enhances immune reactivity to murine tumors: gene therapy in combination with IL-2. Cancer Gene Ther. 1994. 1: 35-42.
68. Tepper, R. I., The tumor-cytokine transplantation assay and the antitumor activity of interleukin-4. Bone Marrow Transplant. 1992. 9: 177-181.
69. Tepper, R. I., Pattengale, P. K. and Leder, P., Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 1989. 57: 503-512.
70. Schuler, T., Qin, Z., Ibe, S., Noben-Trauth, N. and Blankenstein, T., T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J. Exp. Med. 1999. 189: 803-810.
71. Müller, M. R., Grünebach, F., Nencioni, A. and Brossart, P., Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes. J. Immunol. 2003. 170: 5892-5896.
72. Biedermann, T., Lametschwandtner, G., Tangemann, K., Kund, J., Hinteregger, S., Carballido-Perrig, N., Rot, A. et al., IL-12 instructs skin homing of human Th2 cells. J. Immunol. 2006. 177: 3763-3770.